Skip to content
Screener

Illumina ILMN Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Azenta logo
AzentaAZTA
$277.52M
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$408.46M+1.0%
Natera, Inc. logo
Natera, Inc.NTRA
$19.17M
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$19.96M
Guardant Health logo
Guardant HealthGH
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$28.38B+89.2%
Enterprise value$29.29B+81.1%
P/E34.4×+22.5×
P/S6.3×+2.8×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Illumina’s 10-Q, filed May 4, 2026.

Filed
May 3, 2026, 8:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001110803-26-000092
In millionsMarch 29, 2026 / Gross Carrying AmountMarch 29, 2026 / Accumulated AmortizationDecember 28, 2025 / Intangible Assets,NetDecember 28, 2025 / Gross Carrying AmountDecember 28, 2025 / Accumulated AmortizationIntangible Assets,Net
Developed technologies and patents$644$(344)$300$436$(335)$101
Licensed technologies234(150)84234(143)91
Customer relationships28(15)1316(14)2
License agreements25(14)1124(14)10
Trade names18(2)162(2)
Database12(6)612(6)6
Total intangible assets, net$961$(531)$430$724$(514)$210

Cover / Front Matter

FAQ

What is Illumina's finite-lived intangible assets, accumulated amortization?
Illumina (ILMN) reported finite-lived intangible assets, accumulated amortization of $531M in Q1 2026.
What is the long-term trend for Illumina's finite-lived intangible assets, accumulated amortization?
Over 2 years (2020 to 2025), Illumina's finite-lived intangible assets, accumulated amortization has grown at a 20.5% compound annual growth rate (CAGR), from $354M to $514M.

Ask your AI about Illumina's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude